AnaptysBio, Inc.: JPMorgan cuts target price to $60 from $70
ANAB•JPMorgan cut its target price for AnaptysBio to $60 from $70.
Related News
Robinhood to allow 24-hour weekend trading of US stocks as industry shifts to wider access
HOOD•
Vanda Pharmaceuticals announces positive Phase III results for Hetlioz in delayed sleep-wake phase disorder
VNDA•
Oil climbs after Trump denies he is willing to ease sanctions on Iran
USO•
Commodities intraday targets and key levels
USO•
US trade chief to consider trade deal tariff caps in excess capacity probe
SPY•